Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Clonazepam 2 mg Tablets in Healthy Fasting Subjects
NCT06834503Phase 4Not yet recruiting
- Sponsor
- CAIMED
- Start
- Jun 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of clonazepam in epilepsy, panic disorder, sponsored by CAIMED. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
clonazepam
03
Conditions
epilepsypanic disorder
Beyond the preview
Go deeper on NCT06834503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06834503.